Abstract. Malonic acid (MA), methylmalonic acid (MMA), and ethylmalonic acid (EMA) metabolites are implicated in various non-cancer disorders that are associated with inborn-error metabolism. In this study, we have slightly modified the published 3-nitrophenylhydrazine (3NPH) derivatization method and applied it to derivatize MA, MMA, and EMA to their hydrazone derivatives, which were amenable for liquid chromatography-mass spectrometry (LC-MS) quantitation. 3NPH was used to derivatize MA, MMA, and EMA, and multiple reaction monitoring (MRM) transitions of the corresponding derivatives were determined by product-ion experiments. Data normalization and absolute quantitation were achieved by using 3NPH derivatized isotopic labeled compounds 13 C 2 -MA, MMA-D 3 , and EMA-D 3 . The detection limits were found to be at nanomolar concentrations and a good linearity was achieved from nanomolar to millimolar concentrations. As a proof of concept study, we have investigated the levels of malonic acids in mouse plasma with malonyl-CoA decarboxylase deficiency (MCD-D), and we have successfully applied 3NPH method to identify and quantitate all three malonic acids in wild type (WT) and MCD-D plasma with high accuracy. The results of this method were compared with that of underivatized malonic acid standards experiments that were performed using hydrophilic interaction liquid chromatography (HILIC)-MRM. Compared with HILIC method, 3NPH derivatization strategy was found to be very efficient to identify these molecules as it greatly improved the sensitivity, quantitation accuracy, as well as peak shape and resolution. Furthermore, there was no matrix effect in LC-MS analysis and the derivatized metabolites were found to be very stable for longer time.
Introduction
I nborn-errors of metabolism constitutes a wide variety of genetic disorders including Malonyl-CoA decarboxylase deficiency (MCD-D), vitamin B12 deficiency and ethylmalonic encephalopathy (EE) and they have been reported to have serious clinical consequences [1] [2] [3] [4] . MCD-D is a rare autosomal recessively inherited inborn error of fatty acid metabolism that is characterized by malonic aciduria, hypoglycemia, development delay and cardiomyopathy, consanguinity, short stature, abnormal genitalia, renal dysplasia, hypotonia, de novo lipogenesis and brain abnormalities and it may also lead to neonatal deaths [1, [5] [6] [7] [8] . It is reported that the number of patients is increasing every year who carry majority of these clinical features [4, 9] . Malonic acid (MA) metabolite has been shown to be implicated in MCD-D and also known to be a biomarker for de novo lipogenesis (fatty acid synthesis) [10] . Elevated levels of malonic acid were also detected in the patient cerebrospinal fluid (CSF) indicating that it was due to the lack of MCD enzyme [11, 12] . Several mass spectrometry based methods were developed to assess the MCD-D based on the expression level of MA. For example, a new sensitive and specific method was developed for the quantification of serum MA levels based upon a stable isotope-dilution technique using LC-MS [13] .
Vitamin B12 plays an important role in the interconversion of methylmalonyl-CoA to its isomer succinyl-CoA in the odd-chain fatty acid metabolism. Vitamin B12 deficiency was shown to be associated with adverse pregnancy outcomes and poor cognitive performance in children and ageing diseases [14] [15] [16] [17] . Lack of vitamin B12 leads to elevated concentrations of MMA and hence the measurement of methylmalonic acid (MMA) plays an important role in the diagnosis of vitamin B12 deficiency and hence it is the most sensitive and specific metabolite marker for intracellular vitamin-B12 deficiency [18, 19] . Increased MMA levels in plasma and urine were found in patients with vitamin B12 deficiency as a consequence of intestinal malabsorption, impaired digestion, or poor diet [20] . Methylmalonic acidemia covers a spectrum of diseases such as renal insufficiency, hypovolemia, and bacterial overgrowth of the small intestine as well as megaloblastic anemia [21] .
Ethylmalonic acid (EMA) is a biochemical marker for several distinct inborn errors of metabolism with muscular and neurological implications including ethylmalonic encephalopathy (EE) [22, 23] and short-chain acyl-CoA dehydrogenase deficiency (SCADD) [24, 25] . It was found that brain and muscle redox imbalance would result in the elevated levels of EMA which would induce oxidative damage of brain and muscle tissue in SCAD and EE patients [26] . SCAD deficiency is associated with the accumulation of carnitines and EMA and other organic acids in blood, urine and cells [27] . EE is a rare genetic disorder that has only been documented in 30 people in the world until 2012, however, since EMA is implicated in several other diseases in addition to the EE, its early stage diagnosis is critical in all the patients, especially in new born babies who present the related symptoms. MA, MMA, and EMA levels were also found to be altered in patients with severe Malaria and comparison of biochemical pathways implicated in parasite metabolism and severe human febrile illness [28] .
It is evident from the literature that the quantitative analysis of three malonic acids (MA, MMA, and EMA) has received great attention owing to their implications in metabolism related multiple disorders. Targeted metabolomics methods have been extensively applied in the expanded newborn screening for inborn errors of metabolism including MCD, vitamin B12 deficiency and EE [29] [30] [31] . However, the identification of these molecules in plasma urine and other bio specimens has been hampered due to their low physiological concentrations, matrix effect as well as the lack of high sensitive and reliable quantitative analytical methods [28] . Therefore, high sensitive and accurate methods are warranted in the detection and quantitation of malonic acids. In this direction, a few derivatization methods were developed to increase the sensitivity in the quantitative analysis of these malonic acid biomarkers [13, 32] . However, there is no method reported in the literature on the plasma analysis of all of the three malonic acids (MA, MMA and EMA) in a single LC-MS assay which is very essential to screen patients with multiple disorders like MCD-D, Vitamin B12 deficiency and EE etc. 3NPHreagent was demonstrated to be an efficient pre-analytical derivatization reagent that aided the separation, identification and quantitation of thermally unstable and volatile organic compounds as well as metabolites of important biochemical pathways [33] [34] [35] [36] . Here we report an efficient 3NPHchemical derivatization strategy [34] and high sensitive LC-MRM-MS method that enabled the identification and accurate quantitation of MA, MMA, and EMA metabolites in plasma of mouse with wild type and MCD-D. O, and it was used to optimize key reaction conditions. A 5-μL ISTD solution was spiked into 40-μL aliquot of each standard dilution. These solutions were sequentially mixed with 20 μL of 200 mM 3NPH.HCl/50% ACN solution and 20 μL of a mixed 120 mM EDC.HCl -6% pyridine/50% ACN solution in 3-mL borosilicate glass vials. Both of these solutions were freshly prepared in solvents containing different percentages of ACN in H 2 O in order to bring ACN in the final reaction mixtures to 30%, 40%, 50%, 60%, and 70%. These mixtures were reacted individually at different temperatures (10, 20, 30, 40, 50, and 60°C ) and for different time periods (15, 30, 45, 60, 75 , and 90 min). After the reaction, the mixtures were cooled on ice for 1 min and further diluted with 1.915 mL of 10% aqueous ACN. A 5-μL aliquot of each solution was injected into the LC-MS/MS instrument.
Experimental

Materials and Methods
MA
Sensitivity, Linearity, Precision, and Quantitation Accuracy Method sensitivity was determined as the lower limit of detection (LLOD) and lower limit of quantitation (LLOQ) using standard solutions of the 3NPH derivatives of the three acids. In this analysis, a mixture of ISTD spiked solutions of each malonic acid was stepwise diluted into a series of 1-10 with 50% aqueous Extraction of MA, MMA, and EMA from Plasma and Their Derivatization by 3NPH Three different sets of mouse plasma samples were used in this study; they were wild type: WT (n = 3); single knockout: MCD-D (n = 3); and quality control: QC (n = 3) mouse plasma. A mixture of internal standard (ISTD) solutions was freshly made each time, using the three isotopic labeled ISTD compounds (MA-13 C 2 -8.2 mM, MMA-D 3 -8.2 mM, and EMA-D 3 -8.2 mM) and 5 μL of mixture was spiked into each plasma test sample. Forty μL of each plasma sample was transferred into a 3-mL glass vial and was spiked with 5 μL of ISTD mixture solution. Twenty μL of freshly prepared 200 mM 12 C 6 -3NPH-Hcl solution in 50% ACN and 20 μL of freshly prepared 120 mM EDC.HCl in 6% pyridine solution in 50% ACN was added to 40 μL plasma mixture and mixed well. The mixtures were incubated at 40°C for 30 min and subsequently cooled on ice for 1 min; 3NPH derivatization of standard compounds was carried out following similar steps as described above. All the reaction mixtures were diluted with 1.915 mL of 10% aqueous ACN and analyzed by LC-MS in MRM mode. 3 , and EMA-D 3 ; 5 μL of isotopic labeled standard mix was spiked into each standard solution and derivatized with 3NPH; 5-μL of each dilution was injected into LC-MS.
Preparation of Calibration Curve
LC-MRM-MS and Data Analysis
Chromatographic separation of all the target molecules was achieved on ACQUITY UPLC CSH C18 Column (100 Å, 1.8 μm, 2.1 mm × 100 mm) using 0.1% FA in H 2 O (A) and 0.1% FA in ACN (B) mobile phases. The flow rate was 0.35 mL/min. The initial gradient was 15% B at 0 min and it was maintained for 2 min. Then it was increased to 50% B in 10 min and then to 100% B in 0.1 min and maintained for13 min. In order to equilibrate the column before the next experiment, it was decreased to 15% B in 0.1 min and maintained for 4 min. The total run time was 17 min. The HPLC system consisted of an Agilent 1290 series binary pump, online degasser, auto-sampler, and thermostat column compartment (Agilent Technologies, Waldbronn, Germany). The HPLC column temperature was set to 40°C. Mass spectrometry experiments were conducted on an Agilent 6490 triple-quadrupole mass spectrometer (Agilent, Santa Clara, CA, USA) with an Agilent jet stream technology. Tandem mass spectrometry experiments were carried out under negative ion ESI mode with a MRM method. Data analysis was carried out by using Agilent Mass Hunter workstation software. The final concentrations of the target molecules were calculated after normalizing their responses by the responses of corresponding ISTDs. The fold changes were calculated by dividing concentrations of target molecules obtained in MCD-deficiency plasma sample analysis with the concentrations of same target molecules obtained in WT plasma samples.
Results
We have identified and quantitated all three malonic acids by following a published method that successfully investigated many classes of bio-organic compounds [33] [34] [35] [36] . This method relies on the modification of compounds using 3NPH reagent to their hydrazone derivatives followed by their negative ion LC-MRM-MS analysis. In order to monitor the technical errors during sample preparation, we have slightly modified this published method by introducing isotopic labeled compounds of MA, MMA, and EMA [MA-13 C 2 , MMA-D 3 , EMA-D 3 ] in the sample preparation protocol, and the overall workflow followed in this study is given in Figure 1 .
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ACN. The resulting working standard solutions were derivatized with the natural form of 12 C 6 -3NPH and analyzed by and LC/ MRM-MS experiments as described above. The LOD and LOQ were calculated based on the criteria of signal-to-noise ratio less than 10 for the measured peak areas of individual malonic acids. The precision of quantitation was measured as intra-and inter-day coefficients of variation (CVs) by preparing and analyzing three analytical replicates of working ISTD/standard solutions every 6 h within a d and every d for 3 continuous d. The precision of quantitation was also evaluated by determining the %CVs endogenous metabolite concentrations in three replicates of each QC-, WT-, and MCD-deficient plasma. The accuracy of quantitation was evaluated by determining the recoveries of known amounts of spiked-in standard compounds and percent recoveries were calculated as reported previously [34] .
Preparation of WT and MCD-D Plasma Samples
Targeting construct was generated to replace the genomic region containing exon 2 and 3 of the mcd gene with a hypoxanthine phosphorylribosyltransferase (HPRT) cassette. Selected stem cells containing the targeting construct were injected into C57BL/6J blastocysts to produce chimeras. Male chimeras were then mated with 129SV females to obtain mcd +/-(heterozygous) mice. Heterozygous littermates were crossed to produce mcd -/-C57/129 (homozygous) mice. Meanwhile mcd -/-C57/129 mice were backcrossed with 129SV for 8-10 generations to generate a relatively pure line of mcd knockout mcd -/-129 mice. For plasma collection, 6 to 7-mo-old male mice (MCD mutant and wildtype) were placed in metabolic cages individually for 24 h. About 250 μL of blood was collected from each mouse by milking the tail. Blood samples were allowed to clot for 30 min at room temperature before centrifugation for 15 min at 1000× g. Plasma samples were stored at -80°C for further malonic acid analysis.
Development of LC-MRM-MS Method
As described above, first we derivatized MA, MMA, and EMA by the modified 3NPH derivatization protocol and the structures of 3NPH modified malonic acids were confirmed based on their precursor and product-ion mass spectra (Supplementary Figure S-1 ) and the proposed fragmentation mechanism for these molecules has been provided in Supplementary Figure S-2 . In order to develop a robust quantitative method, first we identified unique MRM transitions for all 3NPH derivatized malonic acids and the optimized collision energies, and MRM transitions of all the compounds investigated in this study are given in Supplementary Table S-1. We were able to separate all three derivatized malonic acids in a single LC-MS experiment and identified based on their unique MRM transitions, and the corresponding data are depicted in Figure 2 .
Optimization of 3NPH Chemical Derivatization
We have also optimized key reaction conditions such as ACN %, reaction temperature and reaction time as shown in Figure 3 . Figure 3a shows the effect of the ACN percentage on the derivatization reaction. The data suggests that 30%-70% ACN in the reaction mixture did not produce significant difference in the STD/ISTD peak area ratios and 50% ACN was used for all subsequent experiments in the study. Similarly, Figure 3b and c show the effect of reaction temperature and reaction time. Based on the data in these two plots, 40°C and 30 min were selected as the optimized reaction temperature and reaction time, respectively. Using these optimized reaction conditions, the efficiency of the reaction was examined by LC-MS analysis of malonic acids before and after derivatization of standards as well as plasma samples. The results indicate that 3NPH derivatization is a highly efficient reaction as no traces of free malonic acids were observed in any of the above derivatization reactions, and the corresponding data has been provided in Supplementary Figure S-3 . Thus, complete conversion of malonic acids to their 3-nitrophenylhydrazones was achieved and these results were confirmed by the absence of MRM signals for free malonic acids in the same experiments. We have also investigated the stability of these derivatives and all three malonic acid derivatives showed excellent in-solution stability at 4°C for 14 h, as showed in Figure 4 .
Sensitivity, Linearity, Precision, and Quantitation Accuracy
The data in Table 1 indicate the robustness and reliability of this 3NPH derivatization method to identify and quantitate all . LOD of the malonic acids was 50 nM for MA, 75 nM for MMA, and 120 nM for EMA. LOQ was 360 nM for all three MA, MMA, and EMA molecules. Validation experiments were conducted by spiking 13 C (MA 13 C 2 ) and deuterium (MMA-D 3 and EMA-D 3 ) internal standard mixture and the precision of this method was measured according to the recommended guidelines [37] as intra-and inter-day %CVs for each analyte ( Table 1 ). The intra-day variation was assessed from three replicates within 1 d (n = 3) and inter-day from three times on 3 different d (n = 3). The quantitation accuracy was determined by measuring the concentrations of endogenous malonic acids, and the %CVs for MA, MMA, and EMA in plasma were in all cases <14%. The standard curves generated for this analysis are given in Supplementary Figure S-4 . In order to determine the quantitation accuracy of this method, three aliquots of the pooled mouse plasma sample wereused to measure the endogenous concentrations of the individual malonic acids, and, based on the measured concentration of each malonic acid, known amounts of the standard compounds were spiked into each set of three aliquots of the same plasma sample at 100% of the endogenous levels. The recoveries of each spiked-in compound were measured (Table 2 ) and the concentrations of the three malonic acids in the mouse plasma sample and their measured spike-in recoveries indicate that overall we have achieved very good quantitation accuracy for all three malonic acids.
Quantitation of Malonic Acids in Plasma of WT and MCDDeficient mice
The feasibility of this optimized derivatization strategy and LC-MRM-MS experiments was verified by the analysis of MA, MMA, and EMA that were extracted from mouse plasma. We have successfully derivatized endogenous malonic acids using 3NPH in the plasma of QC, WT, and MCD-deficient mouse as described in the BMaterials and Methods^section, and the corresponding raw data are given in Figure 5 and Supplementary Figure S-5. Three replicates of each QC, WT, and MCD-D plasma samples were used to measure the endogenous concentrations of the individual 3NPH derivatized malonic acids, and Table 3 lists the obtained concentrations and % CVs. These data suggest that reliable identification and accurate quantitation of all three malonic acids is indeed possible using 3NPH derivatization method. We have also noticed significant differences in the malonic acid levels between WT and MCD-D mouse plasma and they were all found to be elevated in the plasma of MCD-deficient mouse. Particularly, MA was elevated >200-fold compared with MMA and EMA, suggesting malonic aciduria in the absence of MCD enzyme ( Figure 6 ).
HILIC Analysis
The complete details of experimental methods of this analysis are provided in Supporting Information ('HILIC method'). HILIC is suitable for separating polar compounds like organic acids, and hence it was combined with mass spectrometry and used for the determination of malonic acids concentration in plasma and urine of various disorders [28, 38, 39] . Table S-2) . Most importantly, sensitivity was found to be very low in the detection of these target molecules in the plasma of control and test samples. Only EMA was identified in the plasma of WT mouse, and MA and MMA were completely absent. This scenario is reversed in the results of plasma analysis of mouse with MCD-D, in which the levels of all MA, MMA, and EMA were found to be elevated many times. However, the total absence of MA and MMA peaks in WT mouse plasma complicated the quantitative analysis for investigating the differential expression of malonic acids between WT and MCDdeficient mouse. Thus, accurate quantitative analysis could not be achieved by HILIC-based method in view of its poor sensitivity, matrix interference, and peak shape and resolution.
Discussion
Malonic acids are aliphatic dicarboxylic acids that are not readily amenable for direct LC-MS analysis due to their hydrophilicity and very low sensitivity even in the negative ion mode [40] . However, in cases of malonic acids analysis, negative ion LC-MS methods are routinely applied and they have already proven to be more efficient than GC-MS method due to the involvement of complex sample preparation/derivatization steps in the latter analytical method. It is indeed important to study MA, MMA, and EMA together as they are all reported to be elevated in patients with multiple diseases like MCD-D and implicated in the brain development and in many other inborn disorders [4] . There is only one study described in the literature on the simultaneous quantitation of all three MA, M MA, and EMA along with other organic acids in the plasma and urine from healthy volunteers and patients with severe malaria [28] . Nevertheless, none of the malonic acids were detected in plasma because of the overall low sensitivity of HILIC strategy though 100 μL of plasma was used for each sample. In view of this, a few derivatization strategies were developed to improve the detection sensitivity of malonic acids in various biospecimens [13, 32, 41] . For example, serum MA was derivatized by 3-hydroxy-1-methylpiperidine and benzoyl and quantified by LC-MSMS in positive ion mode [13] . It was found that the sensitivity was increased 100 times compared with that of MA by LC-MSMS in negative mode. Similarly, serum MMA was esterified by tert-butyl methyl ether (MTBE) reagent in order to monitor the vitamin B12 status in a patient population in a high throughput manner [32] . However, no chemical derivatization method was published in the case of EMA for LC-MS analysis except for the trimethylsilyl derivatization for GC-MS analysis [42] . In this report, we showed that MA, MMA, and EMA can be identified and quantitated in a single MRM assay based on the proof of concept study on the plasma analysis of mouse with WT and MCD-D. As reported previously, patients with MCD-D are characterized by markedly elevated urinary malonic acid, called malonic aciduria [6, 10] . It was also hypothesized that the MA levels may increase in serum due to malonyl-CoA hydrolysis by thio-esterase [13] , which is in agreement with the increased levels of MA in the plasma of MCD-deficient mouse in our current study. 
Advantages of Malonic Acids Derivatization Using 3NPH
3NPH derivatization combined with mass spectrometry is a very powerful quantitative method that has been successfully applied in the detection and quantitation of important classes of organic compounds (bile acids [36] low molecular weight sugars [35] , SCFAs [34] , TCA metabolites [33] , etc.). Based on the literature data, it is evident that 3NPH chemical derivatization of organic compounds will greatly enhance detection sensitivity as well as increase quantitation accuracy. In addition, there are several advantages associated with this efficient 3NPH derivatization in malonic acids analysis compared with other published methods, including HILIC strategy: (1) No interference of unreacted 3NPH and no further purification of reaction products [33] ; (2) labeled ISTDs into plasma samples prior to derivatization would compensate for minor technical errors during sample preparation as well as ESI matrix effects on the quantitation, and it would result in precise and accurate measurements of the malonic acids concentration; (3) high in-solution stability of 3NPH derivatized malonic acids at 4°C for up to 14 h ( Figure 4) ; (4) increased detection sensitivity and excellent chromatographic properties of 3NPH derivatized malonic acid molecules in terms and peak shape and resolution; (5) no background subtraction is necessary in this analysis as we found no noticeable traces prior to standard or test sample analysis, in fact, background subtraction was reported to be an issue in HILIC based method [28] ; (6) only 40 μL of plasma is sufficient for investigating all three malonic acids in a single assay; (7) this method will not have interferences from isomeric compounds, which is usually a problem in underivatized MMA analysis where the isobaric compound succinic acid may interfere and lead to inaccurate quantitation [43] [44] [45] [46] . Although SA and MMA isomeric molecules can be easily separated and quantified in our method, as shown in the Supporting Information (Supplementary Figure S-9 ), (8) there will not be any pitfalls like di-(1-methyl-3-piperidinyl) malonate (DMP-MA) method-anion exchange column interference [13] in which case MA can be produced from unknown substance(s) in organic solvents by this anion exchange column. In view of the above advantages, our method may have great potential to develop as a high throughput clinical [22, 23] SCADD [50] [51] [52] [53] and aciduria [6, 54, 55] , as well as infectious diseases like malaria [28] , in a single LC-MRM-MS assay.
Conclusions
The ultimate goal of this study was to develop an efficient mass spectrometry-based clinical assay to investigate total malonic aciduria by measuring the absolute concentrations of MA, MMA, and EMA metabolites in the biological fluids of patients suffering from various disorders. In this study, we reported for the first time the successful identification and quantitation of MA, MMA, and EMA in plasma using an efficient 3NPH derivatization combined with mass spectrometry. To our knowledge, this is the first report wherein we derivatized two carboxylic acid functional groups in each malonic acid molecule using 3NPH, witnessing the ability of this reagent to modify organic compounds containing multi-carboxylic functional groups to enhance detection sensitivity. Good linearity and precision were obtained, demonstrating the accuracy of the method for quantitative determination of target molecules. This method was further applied to investigate malonic acid metabolites in mouse plasma samples, and we were able to unambiguously identify and quantitate target molecules in submicromolar/nanomolar range concentrations. As validated in this study, our method has great potential to screen various non-cancer genetic, metabolic, and other inherited disorders in patients' plasma, which will be vital for early diagnosis of metabolic diseases accompanying such disorders. The method is well established and tested in MCD-D mouse model. We believe that this study represents an innovative contribution to the determination of MA, MMA, and EMA in plasma and, therefore, it may be suitable for the implementation in routine clinical malonic acids analysis in a newborn screening test as well. Our method is also economically very feasible as concentrations of three targeted malonic acid biomarkers of different disorders can be determined in a single LC-MRM-MS assay. We strongly believe that this new 3NPH chemical derivatization combined with LC-MRM-MS method can also be applied to the quantitative analysis of malonic acids in other types of biological samples such as urine, CSF, etc. 
